Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Neoadjuvant Chemo for NSCLC

This study has been terminated.
(poor accrual)
Sponsor:
Information provided by (Responsible Party):
Glen Weiss, Western Regional Medical Center
ClinicalTrials.gov Identifier:
NCT01860040
First received: May 17, 2013
Last updated: December 8, 2014
Last verified: December 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: April 2016
  Primary Completion Date: September 2014 (Final data collection date for primary outcome measure)